• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

核输入蛋白α1 作为肝细胞癌的一个新的预后靶点。

Importin-α1 as a novel prognostic target for hepatocellular carcinoma.

机构信息

Department of Hepato-Biliary-Pancreatic Surgery, Tokyo Medical and Dental University, Tokyo, Japan.

出版信息

Ann Surg Oncol. 2011 Jul;18(7):2093-103. doi: 10.1245/s10434-011-1569-7. Epub 2011 Feb 1.

DOI:10.1245/s10434-011-1569-7
PMID:21286940
Abstract

BACKGROUND

Perturbations in the nuclear microenvironment, including transport systems, play a critical role in malignant progression, but the nuclear import abnormalities remain unclear in hepatocarcinogenesis. We analyzed the role of importin in hepatocellular carcinoma (HCC).

METHODS

Gene expression profiling of the importin family was performed in HCC tissues. The significance of importin protein expression was analyzed in vitro as well as clinicopathologically.

RESULTS

According to the microarray profiles, the importin-α1 was dominantly overexpressed in HCC tissues as compared to the adjacent noncancerous tissues. By means of human HCC cell lines, a knockdown of importin-α1 by its siRNA greatly reduced cellular proliferation by 15.2-26.6% (P < 0.005). Immunohistochemical analysis on tissue samples demonstrated cancer-specific overexpression in 36.3% of HCCs. The overexpression of importin-α1 was correlated statistically with high levels of alfa-fetoprotein ( P = 0.0017), the tumor number (P = 0.0116), histological dedifferentiation (P = 0.0054), tumor morphology (P = 0.0433), portal vein invasion (P = 0.0007), hepatic vein invasion (P = 0.0081), Fc (P = 0.0367), Fc-inf (P = 0.0122), and the tumor, node, metastasis stage (P = 0.0026); this resulted in a significantly poorer prognosis in both overall survival (P = 0.0164) and recurrence-free survival (P = 0.0101). Multivariate analysis of recurrence-free survival revealed importin-α1 expression to be a statistically significant factor (P = 0.0361). In addition, early recurrence after curative resection was observed more frequently in the importin-α1-positive group as compared to the negative group (P = 0.0023). The multivariate analysis identified importin-α1 as the only independent predictor of early recurrence after HCC resection (odds ratio = 5.291, P = 0.0191).

CONCLUSIONS

Because importin-α1 might be closely associated with HCC progression, further analysis should be pursued to evaluate it as a novel prognostic target.

摘要

背景

核微环境的改变,包括运输系统,在恶性进展中起着至关重要的作用,但在肝癌发生中核输入异常仍不清楚。我们分析了输入蛋白在肝细胞癌(HCC)中的作用。

方法

对 HCC 组织中的输入蛋白家族进行基因表达谱分析。在体外及临床病理方面分析输入蛋白的表达意义。

结果

根据微阵列图谱,与相邻的非癌组织相比,HCC 组织中输入蛋白-α1 明显过表达。通过人 HCC 细胞系,用其 siRNA 敲低输入蛋白-α1 可使细胞增殖减少 15.2-26.6%(P < 0.005)。组织样本的免疫组织化学分析显示 36.3%的 HCC 存在癌特异性过表达。输入蛋白-α1 的过表达与高水平的甲胎蛋白(P = 0.0017)、肿瘤数量(P = 0.0116)、组织学去分化(P = 0.0054)、肿瘤形态(P = 0.0433)、门静脉侵犯(P = 0.0007)、肝静脉侵犯(P = 0.0081)、Fc(P = 0.0367)、Fc-inf(P = 0.0122)和肿瘤、淋巴结、转移分期(P = 0.0026)相关;这导致总体生存率(P = 0.0164)和无复发生存率(P = 0.0101)均显著下降。无复发生存率的多变量分析显示输入蛋白-α1 表达是一个统计学上显著的因素(P = 0.0361)。此外,与阴性组相比,根治性切除术后早期复发更常见于输入蛋白-α1 阳性组(P = 0.0023)。多变量分析确定输入蛋白-α1 是 HCC 切除术后早期复发的唯一独立预测因子(优势比=5.291,P = 0.0191)。

结论

因为输入蛋白-α1 可能与 HCC 的进展密切相关,所以应该进一步分析以评估其作为一种新的预后靶点的可能性。

相似文献

1
Importin-α1 as a novel prognostic target for hepatocellular carcinoma.核输入蛋白α1 作为肝细胞癌的一个新的预后靶点。
Ann Surg Oncol. 2011 Jul;18(7):2093-103. doi: 10.1245/s10434-011-1569-7. Epub 2011 Feb 1.
2
CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.CD24是肝细胞癌术后预后不良的一种新型预测指标。
Clin Cancer Res. 2009 Sep 1;15(17):5518-27. doi: 10.1158/1078-0432.CCR-09-0151. Epub 2009 Aug 25.
3
Overexpression of osteopontin is associated with intrahepatic metastasis, early recurrence, and poorer prognosis of surgically resected hepatocellular carcinoma.骨桥蛋白的过表达与肝内转移、早期复发以及手术切除的肝细胞癌预后较差有关。
Cancer. 2003 Jul 1;98(1):119-27. doi: 10.1002/cncr.11487.
4
NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.NDRG1 作为肝癌转移、复发和预后不良的生物标志物。
Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24.
5
Overexpression of tumour-associated trypsin inhibitor (TATI) enhances tumour growth and is associated with portal vein invasion, early recurrence and a stage-independent prognostic factor of hepatocellular carcinoma.肿瘤相关胰蛋白酶抑制剂(TATI)的过表达会促进肿瘤生长,且与门静脉侵犯、早期复发相关,是肝细胞癌的一个不依赖分期的预后因素。
Eur J Cancer. 2007 Mar;43(4):736-44. doi: 10.1016/j.ejca.2006.11.020. Epub 2007 Jan 30.
6
Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.威斯科特-奥尔德里奇综合征蛋白家族维普洛林同源蛋白2表达增加与肝细胞癌预后不良相关。
Clin Cancer Res. 2006 Oct 1;12(19):5673-9. doi: 10.1158/1078-0432.CCR-06-0022.
7
Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma.肝静脉中血管生成素-2水平可作为人类肝细胞癌肿瘤侵袭性和预后的有效预测指标。
J Gastroenterol Hepatol. 2008 Jul;23(7 Pt 2):e157-64. doi: 10.1111/j.1440-1746.2007.05175.x. Epub 2007 Oct 11.
8
Expression of vascular endothelial growth factor-C in human hepatocellular carcinoma.血管内皮生长因子-C在人肝细胞癌中的表达
J Gastroenterol Hepatol. 2006 Jan;21(1 Pt 1):152-60. doi: 10.1111/j.1440-1746.2005.04217.x.
9
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.富含表皮生长因子的纤维连接蛋白样细胞外基质蛋白 1(EFEMP1),一种使用双重组合微阵列分析在肝细胞癌中检测到的新型肿瘤抑制基因。
Ann Surg Oncol. 2010 Mar;17(3):923-32. doi: 10.1245/s10434-009-0790-0. Epub 2009 Nov 7.
10
ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.ASPM是肝细胞癌血管侵犯、早期复发及预后不良的一种新型标志物。
Clin Cancer Res. 2008 Aug 1;14(15):4814-20. doi: 10.1158/1078-0432.CCR-07-5262.

引用本文的文献

1
Identification and validation of the fibrosis-related molecular subtypes of hepatocellular carcinoma by bioinformatics.通过生物信息学鉴定和验证肝细胞癌的纤维化相关分子亚型
Discov Oncol. 2025 Jun 23;16(1):1180. doi: 10.1007/s12672-025-02964-8.
2
Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management.II期结直肠癌中的蛋白质预后生物标志物:对术后管理的意义。
BJC Rep. 2024 Feb 13;2(1):13. doi: 10.1038/s44276-024-00043-z.
3
Nuclear localization signal-tagged systems: relevant nuclear import principles in the context of current therapeutic design.
核定位信号标记系统:当前治疗设计背景下的相关核输入原理
Chem Soc Rev. 2024 Jan 2;53(1):204-226. doi: 10.1039/d1cs00269d.
4
Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.循环无细胞信使 RNA 使黑色素瘤治疗的非侵入性泛肿瘤监测成为可能,而与突变基因型无关。
Clin Transl Med. 2022 Nov;12(11):e1090. doi: 10.1002/ctm2.1090.
5
Human Enzyme PADI4 Binds to the Nuclear Carrier Importin α3.人源酶 PADI4 与核载体 Importin α3 结合。
Cells. 2022 Jul 11;11(14):2166. doi: 10.3390/cells11142166.
6
mRNA-miRNA bipartite networks reconstruction in different tissues of bladder cancer based on gene co-expression network analysis.基于基因共表达网络分析的膀胱癌不同组织中 mRNA-miRNA 二部网络的重建。
Sci Rep. 2022 Apr 7;12(1):5885. doi: 10.1038/s41598-022-09920-4.
7
MiR-101-3p Suppresses Progression of Cervical Squamous Cell Carcinoma by Targeting and Down-Regulating KPNA2.miR-101-3p 通过靶向和下调 KPNA2 抑制宫颈鳞状细胞癌的进展。
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211055948. doi: 10.1177/15330338211055948.
8
Multiomics-based analyses of KPNA2 highlight its multiple potentials in hepatocellular carcinoma.基于多组学的KPNA2分析突出了其在肝细胞癌中的多种潜力。
PeerJ. 2021 Sep 21;9:e12197. doi: 10.7717/peerj.12197. eCollection 2021.
9
A long non-coding RNA LINC00461-dependent mechanism underlying breast cancer invasion and migration via the miR-144-3p/KPNA2 axis.一种基于长链非编码RNA LINC00461,通过miR-144-3p/KPNA2轴介导乳腺癌侵袭和迁移的机制。
Cancer Cell Int. 2020 Apr 26;20:137. doi: 10.1186/s12935-020-01221-y. eCollection 2020.
10
HCV infection causes cirrhosis in human by step-wise regulation of host genes involved in cellular functioning and defense during fibrosis: Identification of bio-markers.丙型肝炎病毒(HCV)感染通过在纤维化过程中逐步调控参与细胞功能和防御的宿主基因,导致人类肝硬化:生物标志物的鉴定。
Genes Dis. 2019 May 8;6(3):304-317. doi: 10.1016/j.gendis.2019.04.007. eCollection 2019 Sep.